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Aims: The association of dysfunctional bowel elimination with lower urinary tract symptoms is well known in
children, but not in adults. It was our objective to assess lower urinary tract symptoms (LUTS) in women who
report difficult defecation (DD). Methods: This is a secondary analysis of 2,812 women, aged 35–64, who
participated in a telephone interview. All subjects were asked ‘‘When you move your bowels, does the stool come
out easily?’’ DD was considered present in those answering ‘‘no.’’ All subjects were queried regarding
LUTS, urinary infections in the past year, self-perceived health status, medical history, and demographics.
Symptoms of stress incontinence (five items), urge incontinence (five items), and the impact of these symptoms on
their quality of life were solicited from subjects reporting more than 12 episodes of incontinence in 1 year.
Results: DD was reported by 10.4% (290/2,790) of women. Women with DD had higher LUTS than those who
did not: nocturia (mean 1.8 0.1 vs. 1.3 0.0), urgency (47.6% vs. 29.2%), increased daytime frequency (mean
8.2 0.3 vs. 7.2 0.1), dysuria (22.9% vs. 13.7%), and a sensation of incomplete bladder emptying (55.6% vs. 28.2%).
DD women were more often menopausal, reported a fair or poor self-reported health status, and had a higher
number of comorbidities, less formal education, and lower annual household income. Conclusions: Women with
symptoms of DD have an increased rate of LUTS, consistent with the diagnosis of overactive bladder without
incontinence. The pathophysiology underlying this association is worthy of future research. Neurourol. Urodynam.
29:1290–1294, 2010.  2010 Wiley-Liss, Inc.
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AIMS
An association in children between constipation and
lower urinary tract symptoms (LUTS) is a relatively recently
appreciated phenomenon.1 In the majority of children, func-
tional rather than anatomical abnormalities are often respon-
sible for urinary tract infections, urinary incontinence (UI),
urgency, and frequency. These neurologically normal children
were previously labeled as ‘‘dysfunctional voiders’’ and were
given bladder retraining and timed voiding as treatment.
However, this perception changed dramatically after it was
shown that constipation and voluntary fecal retention was
actually the major contributor to their urinary symptoms. By
treating the constipation daytime incontinence was relieved
in 90% of children and recurrence of urinary tract infections
was eliminated.1 The constellation of childhood symptoms of
constipation, fecal incontinence, and painful bowel move-
ments combined with urinary symptoms of frequent urinary
tract infections, urge incontinence, urgency, and frequency in
the anatomically normal child is now called dysfunctional
elimination (DE) syndrome.2
There exist some data about the link between bowel and
bladder symptoms in the adult,3,4 but unless a woman is being
seen by a physician who specialized in pelvic medicine there is
usually no one physician who queries her about both of these
symptoms.
Two studies have investigated the impact of having had DE
as a child on symptoms as an adult. Both of these studies have
found that adult women with LUTS reported more childhood
DE symptoms than women who did not.5,6 Little is known
about the urologic impact of adult dysfunctional bowel
elimination, or difficult defecation (DD) in adults.
Based on clinical observations and the known association
between bowel and bladder symptoms in children we
hypothesized that women with DD would have more LUTS
than women who do not. Our aim was to assess if LUTS are
more common in women that report DD. The LUTS of
particular interest included overactive bladder (urgency with
or without urgency incontinence, frequency, and nocturia)
and stress incontinence.
METHODS
This is a secondary analysis of 2,812 community dwelling
women, aged 35–64, who participated in a telephone inter-
view as part of an epidemiologic study of UI prevalence
amongWhite and Black women.7 These women were sampled
from 12,541 telephone records from three southeast Michigan
counties with the study goal of interviewing 1,500 black
women and 1,000 white women. The research protocol was
approved by the institutional review board of the University
of Michigan Medical School (IRB#2000-0824).
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Information brochures and a letter introducing the study
were mailed to the address associated with the telephone
number and soon thereafter a trained female professional
telephone interviewer from the Survey Research Center of the
University of Michigan Institute for Social Research called the
household to screen for eligible participants. Inclusion criteria
were women between the ages of 35 and 64 who self-
identified as black or white race who had not been pregnant in
the past 12 months. Eligible women who consented verbally
were assessed for demographic characteristics, health history,
lifestyle factors, obstetric, and gynecologic history and LUTS
including UI.
The protocol for the sampling of the population and for the
questionnaire survey has been described.7 There was a 69%
response rate.
All subjects were asked ‘‘When you move your bowels, does
the stool come out easily?’’ DD was considered present in
those answering ‘‘no.’’ The answers of women with and
without DD were compared with respect to number of bowel
movements per week, bladder storage symptoms per ICS
Standardized terminology (number of nocturia episodes, the
presence of urgency, and UI), number of daytime voids
(frequency), presence of urinary infections in the past year,
dysuria, feelings of incomplete emptying, and the need to
locate the nearest toilet as soon as arriving at a new place. The
women were also asked to rate their self-perceived health
status as excellent, very good, good, fair, or poor. Any woman
who reported leaking urine 12 or more times in the past
12 months was asked additional questions regarding their
urine loss. These included five items specific to symptoms of
stress incontinence, and five items specific to urge incon-
tinence as well as the impact of these symptoms on their
quality of life as assessed by the incontinence impact
questionnaire-7 (IIQ-7).8 This questionnaire yields a summed
score ranging from 0 to 100 with higher scores indicating a
greater degree of distress.
Student’s t-tests and chi-square analysis were used to
evaluate the association of DD with demographics, LUTS,
bowel movement frequency, and perception of health status.
Multivariable logistic regression was used to calculate odds
ratios adjusted for age, household income, education, hyster-
ectomy status, previous prolapse surgery, and self-perceived
health status. P-values <0.05 were considered statistically
significant. Stata (version 9.2, College Station, TX) was used for
all analyses.
RESULTS
DDwas reported by 10.4% (290/2,790) of women enrolled in
the study. Women with DD were more likely than were those
without to have three or fewer bowel movements per week
(46.5% vs. 11.7%, adjusted OR: 5.8, 95% CI: 4.2–8.0). Fecal
incontinence was not more likely to be experienced by women
with DD compared to those without DD (18.8% vs. 13.4%,
adjusted OR: 1.2, 95% CI: 0.81–1.8).
The demographic data of the women with and without DD
are presented in Table I. Women with DD reported a higher
mean number of comorbidities and were more likely than
those without DD to be post-menopausal, to have had a
hysterectomy or prolapse surgery, to have not completed the
twelfth grade, to report an income of less than $25,000, and to
report a self-perceived health status of ‘‘fair’’ or ‘‘poor.’’ The
groups did not differ with respect to age, mean parity, marital
status, race, past incontinence surgery, or the use of estrogen
replacement.
Lower urinary tract and bowel symptoms are reported in
Table II. The constellation of symptoms commonly referred to
as ‘‘dry’’ overactive bladder which includes urinary urgency,
frequency, and nocturia was more common among women
with DD. Women with DD were also more likely to have a
sensation of incomplete emptying, dysuria, and urinary tract
infections than were those without DD.
UI was common among women with DD. Subsets of women
reporting symptoms were evaluated in a stepwise fashion
based on severity of symptoms (Fig. 1). Women with DD were
more likely than those without DD to report that they had
experienced any UI (61.1% vs. 42.9%, adjusted OR: 2.4, 95% CI:
1.6–2.7). Among those reporting any UI, women with DD were
also more likely than those without DD to report that they
experienced ‘‘more than 12 episodes in the last year’’ (56% vs.
44%, adjusted OR: 1.6, 95% CI: 1.1–2.3). Those women who
answered yes to both of these questions (n¼ 563) were further
queried about symptoms of stress and urgency associated
incontinence. Although the rates of specific symptoms did not
differ (Table III), the perceived impact of these symptoms on
quality of life was much greater among those with DD (mean
IIQ-7 score SD: 33.5 26.4 vs. 23.7 23.8, P¼ 0.004). The
incontinent group was also asked ‘‘how are you managing your
incontinence?’’ In the DD group 9.56% indicated that they were
taking medication (specific type not specified) and in the DD
absent group 8.01% with P-value of 0.8.
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Age (years) 49.6 49.9 0.57
Mean parity 2.81 2.89 0.89
Education 12th grade or less completed 37.50% 28.76% 0.007
Household income <25K/year 30.05% 20.45% 0.017
Marital status—married 46.3% 48.5% 0.189
Race—African-American 65.97% 68.72% 0.343
Past hysterectomy 31.25% 21.65% <0.001
History of prolapse surgery 7.64% 4.00% 0.004
History of incontinence surgery 3.13% 1.71% 0.094
Post-menopausal 61.75% 48.55% <0.001
Estrogen replacement 14.04% 10.73% 0.093
Number of comorbidities SE (n¼ 2,733) 1.9 0.1 1.4 0.02 <0.001
Self-perceived health status (n¼ 2,750)
Excellent to very good 31.3% 47.6% 0.04
Good 34.0% 35.1%
Fair/poor 34.7% 17.3%
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DISCUSSION
Women with symptoms of DD have an increased rate of
bladder storage symptoms, consistent with the diagnosis of
overactive bladder without incontinence, or so-called ‘‘dry
OAB.’’ They have more incontinence, but it is not specifically
urgency or stress incontinence. These women also report more
dysuria, urinary tract infections, and a sensation of incom-
plete emptying. Symptoms of UI are more common among
women with DD, and these symptoms have a more negative
impact on their quality of life as measured by the IIQ-7. This
constellation of symptoms is similar, but not identical to
pediatric DE.
Pediatric DE is characterized by the combination of bowel
and bladder symptoms such as fecal incontinence, constipa-
tion, urinary tract infections (UTI), urgency, frequency, and UI.
These symptoms together are called DE and are a well-known
entity in pediatrics.2 The root cause of these combined
symptoms is felt to be primarily constipation. When con-
stipation is successfully treated in children with DE, without
any specific treatment for the urinary symptoms, 89% of the
children are cured of daytime UI, 63% have disappearance of
their of nighttime incontinence, and all anatomically normal
children have disappearance of UTIs.1 Empiric support such as
this is not available in women but there is epidemiologic
evidence to suggest that a constellation of symptoms similar
to those seen in children can affect women.
A relationship between adult urogynecology patients and
childhood DE has been established. Bower et al. surveyed 191
women attending an urogynecology clinic and 251 women
attending other clinics about their current DE symptoms and
those when they were children. There were significantly
higher DE scores as children in women who were attending
the urogynecology clinic and 41.7% of the UG women could be
labeled as DE now. The authors concluded that a history of DE
syndrome as a child results in more bowel and bladder
problems as an adult.6 Minassian et al. found similar results
when they surveyed 170 women attending gynecology clinics.
The women who reported a history of childhood DE currently
had more urinary frequency, urgency, SUI, and UUI.5
There is also the possibility that DE syndrome that occurs in
children is a completely different disorder altogether than the
constellation of symptoms present in our adult population. In
the few articles that address both bowel and bladder disorders
together, symptoms of OAB and anal incontinence or
constipation were found to overlap significantly, but the
main risk factor for these combined symptoms was uterova-
ginal prolapse.9 It has been reported that 10–40% of women
with anorectal incontinence have SUI or prolapse.10,11 How-
ever, in this analysis the difference in bladder symptoms held
true when controlling for prolapse in the logistic regression.
The question arises: what about DD, or difficulty emptying
stool from the rectum, could possibly cause overactive bladder
symptoms combined with other LUTS? Rectal distention from
a stool bolus is the normal stimulus for defecation. If
evacuation is delayed one has to contract the external
sphincter and puborectalis to cause the fecal urgency to
subside until the next fecal bolus arrives. Over time, if this
behavior of maintaining chronic anal sphincter tone persists,
the rectum gets over distended and the pelvic floor becomes
hypertonic and this may persist. This is referred to as fecal
hoarding in children and is felt to be a major contributor to
childhood OAB symptoms.12
If the rectum does not empty well the fecal mass that is
stored in the rectum and sigmoid may exert pressure on the
bladder wall, decreasing functional bladder capacity like a
gravid uterus compresses the bladder during pregnancy
leading to overactive bladder symptoms13 or that the stretch
receptors in the bladder wall are stimulated by the fecal mass
triggering uninhibited detrusor contractions.12,14 It is also
possible that colonic contractions may trigger detrusor
contractions through a shared neurological pathway in the
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TABLE II. Lower Urinary Tract Symptoms in Group With Difficult Defecation Compared to Those Without
Difficult defecation





Frequent strong sudden urges to urinate (n¼ 2,739) 47.6% 29.2% 2.20 (1.71–2.81) 2.43 (1.79–3.31)
Nocturia episodes (n¼ 2,741) 1.8 0.1 1.3 0.02 1.32 (1.20–1.44) 1.31 (1.17–1.48)
Daytime urinary frequency episodes (n¼ 2,750) 8.2 0.3 7.2 0.1 1.06 (1.03–1.09) 1.06 (1.02–1.10)
Locate nearest toilet as soon as arriving at a new place
(n¼ 2,739)
32.17% 18.7% 2.06 (1.58–2.67) 2.09 (1.51–2.91)
Dysuria (n¼ 2,750) 22.9% 13.7% 1.41 (1.12–1.79) 1.42 (1.04–1.94)
UTI in past year (n¼ 2,750) 18.8% 12.2% 1.67 (1.22–2.31) 1.64 (1.11–2.44)
Sense of incomplete emptying (n¼ 2,743) 55.6% 28.2% 3.19 (2.48–4.09) 3.31 (2.43–4.52)
Data presented are mean SE unless otherwise noted.
aLogistic regression controlling for age income education less than grade 12, history of hysterectomy, history of prolapse surgery.
*P< 0.004 for all values.
2747 women in phone survey

















“…more than 12 episodes in a year”
Types of urinary incontinence, impact on QOL
“…any urinary incontinence other than drops after urinating?”
Fig. 1. Difficult defecation (DD) and urinary incontinence inclusion groups.
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spinal cord or pelvic nerves.15This has also been seen in an
animal model where colonic contractions from acute colitis
increases voiding symptoms in rats.16,17
There may be a central nervous system alteration that is
responsible for these combined bowel and bladder symptoms.
Afferent nerves in the sigmoid, rectum, and bladder all send
information to the spinal cord via the pelvic nerve and pelvic
parasympathetic nerves mediate both bowel and bladder
emptying. Therefore, an afferent neural pathway disorder
could explain the combined hypersensitive bowel and bladder
occurring together. Sacral nerve stimulation has had good
success in treating both urgency and frequency symptoms as
well as chronic defecation disorders, despite identical place-
ment of the stimulation lead in the S3 foramina for both
indications. Therefore, this theory of a common neurological
pathway is plausible.18
Many other genitourinary symptoms have been shown to
overlap in a similar fashion as the bowel and bladder
symptoms in this analysis. Bladder symptoms that define
interstitial cystitis/painful bladder syndrome (IC/PBS) and
bladder outlet obstruction have been shown to overlap and
exist together more frequently than would be expected by
chance in the Boston Area Community Health Survey. This
survey queried over 3,000 racially diverse community dwell-
ing women and found that 0.5% of the women reported pure
symptoms of IC/PBS, 11.4% reported pure obstructive-type
symptoms, and 1.1% reported both, making the overlap of
symptoms more than twice as prevalent as pure IC/PBS
symptoms.19
There are several factors that should be kept in mind in
interpreting the results of this analysis. This group of women
was recruited from women 35 to 64 years of age in a small
geographical area in Michigan. The generalizability of the
results to women of other ages or living in other parts of North
America remains to be defined. Also no Latina or Asian-
American women were recruited so these results cannot be
applied to these populations. This study was not designed to
measure defecatory dysfunction specifically, and a more
complete bowel questionnaire is needed to fully evaluate
these symptoms. Our hypothesis that this disorder may be
related to childhood DE is not assessable since childhood
elimination symptoms were not asked of this population.
This association between bowel and bladder symptoms in
women has clinical implications. It is well known that
treatment of these bowel symptoms in children dramatically
reduces urinary infections and UI.20 The treatment of these
bowel symptoms in women could potentially be equally
efficacious. It is our suggestion that all women with OAB
symptoms should be queried about their bowel symptoms
and any defecatory dysfunction addressed simultaneously
with the OAB due to their probable interrelation. Unfortu-
nately, the mainstay of pharmacological treatment for OAB
is antimuscarinic agents who have the potential side
effect of constipation in approximately 7%.21 Further study
needs to be done to confirm that treatment of the bowel
symptoms in the adult female will improve their bladder
symptoms if these measures are certainly not harmful and are
potentially beneficial not only to the bowel, but to bladder
symptoms.
CONCLUSION
Women with symptoms of defecatory dysfunction have an
increased rate of bladder storage symptoms, consistent with
the diagnosis of overactive bladder without urge inconti-
nence, or dry OAB. Understanding the pathophysiology
underlying this association and exploring treatment options
that address these combined symptoms is worthy of future
research.
ACKNOWLEDGMENTS
This research was supported by NIH R01HD/AG41123-01
with additional investigator support from Office for Research
on Women’s Health and the National Institute of Child Health
and Human Development SCOR 1 P50 HD044406.
REFERENCES
1. Loening-Baucke V. Urinary incontinence and urinary tract infection and their
resolution with treatment of chronic constipation of childhood. Pediatrics
1997;100:228–32.
2. Feng WC, Churchill BM. Dysfunctional elimination syndrome in children
without obvious spinal cord diseases. Pediatr Clin North Am 2001;48:1489–
504.
3. van Gerwen M, Schellevis F, Lagro-Janssen T. Comorbidities associated
with urinary incontinence: A case–control study from the Second Dutch
National Survey of General Practice. J Am Board Fam Med 2007;20:
608–10.
4. Damon H, Schott AM, Barth X, et al. Clinical characteristics and quality of life
in a cohort of 621 patients with faecal incontinence. Int J Colorectal Dis
2008;23:845–51.
5. Minassian VA, Lovatsis D, Pascali D, et al. Effect of childhood dysfunctional
voiding on urinary incontinence in adult women. Obstet Gynecol 2006;
107:1247–51.
6. Bower WF, Yip SK, Yeung CK. Dysfunctional elimination symptoms in
childhood and adulthood. J Urol 2005;174:1623–7, discussion 1627–8.
7. Fenner DE, Trowbridge ER, Patel DA, et al. Establishing the prevalence of
incontinence study: Racial differences in women’s patterns of urinary
incontinence. J Urol 2008;179:1455–60.
8. Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality
and symptom distress for urinary incontinence in women: The Incontinence
Impact Questionnaire and the Urogenital Distress Inventory. Continence
Program for Women Research Group. Neurourol Urodyn 1995;14:131–9.
9. Ng SC, Chen YC, Lin LY, et al. Anorectal dysfunction in women with urinary
incontinence or lower urinary tract symptoms. Int J Gynaecol Obstet 2002;
77:139–45.
10. Delechenaut P, Leroi AM, Weber J, et al. Relationship between clinical
symptoms of anal incontinence and the results of anorectal manometry. Dis
Colon Rectum 1992;35:847–9.
11. Jackson SL, Weber AM, Hull TL, et al. Fecal incontinence in women with
urinary incontinence and pelvic organ prolapse. Obstet Gynecol 1997;89:
423–7.
12. Franco I. Overactive bladder in children. Part 2: Management. J Urol 2007;
178:769–74, discussion 774.
13. Belman AB, King LR, Kramer LA, editors. Clinical pediatric urology. London:
Martin Dunitz Ltd; 2002.
14. Fernandes E, Vernier R, Gonzalez R. The unstable bladder in children. J Pediatr
1991;118:831–7.
Neurourology and Urodynamics DOI 10.1002/nau
TABLE III. Urinary Incontinence Symptoms Among Women Who Have




SUI: with cough/laugh/sneeze 49.5 48.4 0.9
SUI: with lifting 9.2 10.4 0.3
SUI: straining 7.2 9.1 0.06
SUI: exercise 9.3 11.9 0.5
SUI: sexual incontinence 2.1 4.1 0.5
UUI: when you have a cold 9.3 6.0 0.4
UUI: when you put keys in lock 18.6 21.6 0.9
UUI: hearing water run 12.4 13.3 0.8
UUI: with little warning 25.8 23.4 0.2
UUI: can’t find toilet 23.7 14.8 0.2
SUI, stress urinary incontinence; UUI, urgency urinary incontinence.
Difficult Defecation in OAB 1293
15. Warne SA, Godley ML, Wilcox DT. Surgical reconstruction of cloacal
malformation can alter bladder function: A comparative study with
anorectal anomalies. J Urol 2004;172:2377–81, discussion 2381.
16. PezzoneMA, Liang R, Fraser MO. Amodel of neural cross-talk and irritation in
the pelvis: Implications for the overlap of chronic pelvic pain disorders.
Gastroenterology 2005;128:1953–64.
17. Ustinova EE, Fraser MO, Pezzone MA. Colonic irritation in the rat sensitizes
urinary bladder afferents to mechanical and chemical stimuli: An afferent
origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol 2006;
290:F1478–87.
18. Jarrett ME. Neuromodulation for constipation and fecal incontinence. Urol
Clin North Am 2005;32:79–87.
19. Barry MJ, Link CL, McNaughton-Collins MF, et al. Overlap of different
urological symptom complexes in a racially and ethnically diverse,
community-based population of men and women. BJU Int 2008;101:
45–51.
20. Neveus T. The standardization of terminology of lower urinary tract
function in children and adolescents: Report from the Standardisation
Committee of the International Children’s Continence Society. J Urol 2006;
176:314.
21. Diokno AC, Appell RA, Sand PK, et al. Prospective, randomized, double-blind
study of the efficacy and tolerability of the extended-release formulations of
oxybutynin and tolterodine for overactive bladder: Results of the OPERA
trial. Mayo Clin Proc 2003;78(6):687–695.
Neurourology and Urodynamics DOI 10.1002/nau
1294 Cameron et al.
